|
1.
|
D LavanchyThe global burden of hepatitis
CLiver Int29Suppl 1S74S81200910.1111/j.1478-3231.2008.01934.x
|
|
2.
|
N BostanT MahmoodAn overview about
hepatitis C: a devastating virusCrit Rev
Microbiol3691133201010.3109/1040841090335745520345213
|
|
3.
|
D MoradpourF PeninCM RiceReplication of
hepatitis C virusNat Rev
Microbiol5453463200710.1038/nrmicro1645
|
|
4.
|
JJ FeldJH HoofnagleMechanism of action of
interferon and ribavirin in treatment of hepatitis
CNature436967972200510.1038/nature0408216107837
|
|
5.
|
S MunirS SaleemM IdreesHepatitis C
treatment: current and future perspectivesVirol
J7296201010.1186/1743-422X-7-29621040548
|
|
6.
|
BD LindenbachCM RiceUnravelling hepatitis
C virus replication from genome to
functionNature436933938200510.1038/nature0407716107832
|
|
7.
|
CM LeeCH HungSN LuViral etiology of
hepatocellular carcinoma and HCV genotypes in
TaiwanIntervirology497681200610.1159/00008726716166793
|
|
8.
|
H HatcherR PlanalpJ ChoFM TortiSV
TortiCurcumin: from ancient medicine to current clinical trialsCell
Mol Life Sci6516311652200810.1007/s00018-008-7452-418324353
|
|
9.
|
A GoelAB KunnumakkaraBB AggarwalCurcumin
as ‘Curecumin’: from kitchen to clinicBiochem
Pharmacol757878092008
|
|
10.
|
CJ LiLJ ZhangBJ DezubeCS CrumpackerAB
PardeeThree inhibitors of type 1 human immunodeficiency virus long
terminal repeat-directed gene expression and virus replicationProc
Natl Acad Sci USA9018391842199310.1073/pnas.90.5.18398446597
|
|
11.
|
A MazumderK RaghavanJ WeinsteinKW KohnY
PommierInhibition of human immunodeficiency virus type-1 integrase
by curcuminBiochem
Pharmacol4911651170199510.1016/0006-2952(95)98514-A7748198
|
|
12.
|
X SiY WangJ WongJ ZhangBM McManusH
LuoDysregulation of the ubiquitin-proteasome system by curcumin
suppresses coxsackievirus B3 replicationJ
Virol8131423150200710.1128/JVI.02028-0617229707
|
|
13.
|
MM RechtmanO Har-NoyI Bar-YishayCurcumin
inhibits hepatitis B virus via down-regulation of the metabolic
coactivator PGC-1alphaFEBS
Lett58424852490201010.1016/j.febslet.2010.04.06720434445
|
|
14.
|
K KimKH KimHY KimHK ChoN SakamotoJ
CheongCurcumin inhibits hepatitis C virus replication via
suppressing the Akt-SREBP-1 pathwayFEBS
Lett584707712201010.1016/j.febslet.2009.12.01920026048
|
|
15.
|
LE OtterbeinMP SoaresK YamashitaFH
BachHeme oxygenase-1: unleashing the protective properties of
hemeTrends
Immunol24449455200310.1016/S1471-4906(03)00181-912909459
|
|
16.
|
TO KhorMT HuangKH KwonJY ChanBS ReddyAN
KongNrf2-deficient mice have an increased susceptibility to dextran
sulfate sodium-induced colitisCancer
Res661158011584200610.1158/0008-5472.CAN-06-356217178849
|
|
17.
|
R MotterliniR ForestiR BassiCJ
GreenCurcumin, anti-oxidant and anti-inflammatory agent, induces
heme oxygenase-1 and protects endothelial cells against oxidative
stressFree Radic Biol
Med2813031312200010.1016/S0891-5849(00)00294-X10889462
|
|
18.
|
J GaedekeNA NobleWA BorderCurcumin blocks
fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of
heme oxygenase 1Kidney
Int6820422049200510.1111/j.1523-1755.2005.00658.x16221204
|
|
19.
|
SJ McNallyEM HarrisonJA RossOJ GardenSJ
WigmoreCurcumin induces heme oxygenase-1 in hepatocytes and is
protective in simulated cold preservation and warm reperfusion
injuryTransplantation81623626200610.1097/01.tp.0000184635.62570.1316495813
|
|
20.
|
W BaoK LiS RongCurcumin alleviates
ethanol-induced hepatocytes oxidative damage involving heme
oxygenase-1 inductionJ
Ethnopharmacol128549553201010.1016/j.jep.2010.01.02920080166
|
|
21.
|
EO FarombiS ShrotriyaHK NaSH KimYJ
SurhCurcumin attenuates dimethylnitrosamine-induced liver injury in
rats through Nrf2-mediated induction of heme oxygenase-1Food Chem
Toxicol4612791287200810.1016/j.fct.2007.09.09518006204
|
|
22.
|
KM KimHO PaeM ZhungInvolvement of
anti-inflammatory heme oxygenase-1 in the inhibitory effect of
curcumin on the expression of pro-inflammatory inducible nitric
oxide synthase in RAW264.7 macrophagesBiomed
Pharmacother62630636200810.1016/j.biopha.2008.01.00818325727
|
|
23.
|
HY HsuLC ChuKF HuaLK ChaoHeme oxygenase-1
mediates the anti-inflammatory effect of Curcumin within
LPS-stimulated human monocytesJ Cell
Physiol215603612200810.1002/jcp.2120618357586
|
|
24.
|
K DevadasS DhawanHemin activation
ameliorates HIV-1 infection via heme oxygenase-1 inductionJ
Immunol17642524257200610.4049/jimmunol.176.7.425216547262
|
|
25.
|
U ProtzerS SeyfriedM QuasdorffAntiviral
activity and hepatoprotection by heme oxygenase-1 in hepatitis B
virus
infectionGastroenterology13311561165200710.1053/j.gastro.2007.07.02117919491
|
|
26.
|
E LehmannWH El-TantawyM OckerThe heme
oxygenase 1 product biliverdin interferes with hepatitis C virus
replication by increasing antiviral interferon
responseHepatology51398404201010.1002/hep.2333920044809
|
|
27.
|
Y ShanJ ZhengRW LambrechtHL
BonkovskyReciprocal effects of micro-RNA-122 on expression of heme
oxygenase-1 and hepatitis C virus genes in human
hepatocytesGastroenterology13311661174200710.1053/j.gastro.2007.08.00217919492
|
|
28.
|
Z ZhuAT WilsonMM MathahsHeme oxygenase-1
suppresses hepatitis C virus replication and increases resistance
of hepatocytes to oxidant
injuryHepatology4814301439200810.1002/hep.2249118972446
|
|
29.
|
V TergaonkarNFkappaB pathway: a good
signaling paradigm and therapeutic targetInt J Biochem Cell
Biol3816471653200610.1016/j.biocel.2006.03.02316766221
|
|
30.
|
S LuqmanJM PezzutoNFkappaB: a promising
target for natural products in cancer chemopreventionPhytother
Res24949963201020577970
|
|
31.
|
Y ZhongT LiuZ GuoCurcumin inhibits
ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and
NF-kappaB pathways in rat vascular smooth muscle cellsInflamm
Res616167201210.1007/s00011-011-0389-322005927
|
|
32.
|
C JobinCA BradhamMP RussoCurcumin blocks
cytokine-mediated NF-kappa B activation and proinflammatory gene
expression by inhibiting inhibitory factor I-kappa B kinase
activityJ Immunol16334743483199910477620
|
|
33.
|
AC BhartiN DonatoS SinghBB
AggarwalCurcumin (diferuloylmethane) down-regulates the
constitutive activation of nuclear factor-kappa B and IkappaBalpha
kinase in human multiple myeloma cells, leading to suppression of
proliferation and induction of
apoptosisBlood10110531062200310.1182/blood-2002-05-1320
|
|
34.
|
GL JohnsonR LapadatMitogen-activated
protein kinase pathways mediated by ERK, JNK, and p38 protein
kinasesScience29819111912200210.1126/science.107268212471242
|
|
35.
|
A ChenS ZhengCurcumin inhibits connective
tissue growth factor gene expression in activated hepatic stellate
cells in vitro by blocking NF-kappaB and ERK signallingBr J
Pharmacol153557567200810.1038/sj.bjp.070754217965732
|
|
36.
|
JH LimTK KwonCurcumin inhibits phorbol
myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK
and NF-kappaB transcriptional activityFood Chem
Toxicol484752201010.1016/j.fct.2009.09.01319766691
|
|
37.
|
A ShehzadF WahidYS LeeCurcumin in cancer
chemo-prevention: molecular targets, pharmacokinetics,
bioavailability, and clinical trialsArch
Pharm343489499201010.1002/ardp.20090031920726007
|
|
38.
|
MP SoaresFH BachHeme oxygenase-1: from
biology to therapeutic potentialTrends Mol
Med155058200910.1016/j.molmed.2008.12.00419162549
|
|
39.
|
Z ZhuAT WilsonBA LuxonBiliverdin inhibits
hepatitis C virus nonstructural 3/4A protease activity: mechanism
for the antiviral effects of heme
oxygenase?Hepatology5218971905201010.1002/hep.2392121105106
|
|
40.
|
C FillebeenK PantopoulosIron inhibits
replication of infectious hepatitis C virus in permissive Huh7.5.1
cellsJ Hepatol53995999201010.1016/j.jhep.2010.04.04420813419
|
|
41.
|
J ChoiKJ LeeY ZhengAK YamagaMM LaiJH
OuReactive oxygen species suppress hepatitis C virus RNA
replication in human hepatoma
cellsHepatology398189200410.1002/hep.2000114752826
|
|
42.
|
M YanoM IkedaK AbeOxidative stress induces
anti-hepatitis C virus status via the activation of extracellular
signal-regulated
kinaseHepatology50678688200910.1002/hep.2302619492433
|
|
43.
|
M KurokiY AriumiM IkedaH DansakoT WakitaN
KatoArsenic trioxide inhibits hepatitis C virus RNA replication
through modulation of the glutathione redox system and oxidative
stressJ Virol8323382348200910.1128/JVI.01840-0819109388
|
|
44.
|
DP BrazilZZ YangBA HemmingsAdvances in
protein kinase B signalling: AKTion on multiple frontsTrends
Biochem Sci29233242200410.1016/j.tibs.2004.03.00615130559
|
|
45.
|
P MannovaL BerettaActivation of the
N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell
survival and viral replicationJ
Virol7987428749200510.1128/JVI.79.14.8742-8749.200515994768
|
|
46.
|
A StreetA MacdonaldK CrowderM HarrisThe
Hepatitis C virus NS5A protein activates a phosphoinositide
3-kinase-dependent survival signaling cascadeJ Biol
Chem2791223212241200410.1074/jbc.M31224520014709551
|
|
47.
|
T PorstmannB GriffithsYL ChungPKB/Akt
induces transcription of enzymes involved in cholesterol and fatty
acid biosynthesis via activation of
SREBPOncogene2464656481200516007182
|
|
48.
|
CY ParkHJ JunT WakitaJH CheongSB
HwangHepatitis C virus nonstructural 4B protein modulates sterol
regulatory element-binding protein signaling via the AKT pathwayJ
Biol Chem28492379246200910.1074/jbc.M80877320019204002
|
|
49.
|
D Yangxand GabuzdaRegulation of human
immunodeficiency virus type 1 infectivity by the ERK
mitogen-activated protein kinase signaling pathwayJ
Virol7334603466199910074203
|
|
50.
|
S PleschkaT WolffC EhrhardtInfluenza virus
propagation is impaired by inhibition of the Raf/MEK/ERK signalling
cascadeNat Cell Biol3301305200110.1038/3506009811231581
|
|
51.
|
Y CaiY LiuX ZhangSuppression of
coronavirus replication by inhibition of the MEK signaling pathwayJ
Virol81446456200710.1128/JVI.01705-0617079328
|
|
52.
|
KD SmithJJ MezhirK BickenbachActivated MEK
suppresses activation of PKR and enables efficient replication and
in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex
virus 1J
Virol8011101120200610.1128/JVI.80.3.1110-1120.200616414988
|
|
53.
|
Y ZhengJ LiDL JohnsonJH OuRegulation of
hepatitis B virus replication by the ras-mitogen-activated protein
kinase signaling pathwayJ
Virol7777077712200310.1128/JVI.77.14.7707-7712.200312829809
|
|
54.
|
H ZhuC LiuInterleukin-1 inhibits hepatitis
C virus subgenomic RNA replication by activation of extracellular
regulated kinase pathwayJ
Virol7754935498200310.1128/JVI.77.9.5493-5498.200312692250
|
|
55.
|
T MurataM HijikataK ShimotohnoEnhancement
of internal ribosome entry site-mediated translation and
replication of hepatitis C virus by
PD98059Virology340105115200510.1016/j.virol.2005.06.01516005928
|
|
56.
|
J NdjomouIW ParkY LiuLD MayoJJ
HeUp-regulation of hepatitis C virus replication and production by
inhibition of MEK/ERK signalingPLoS
One4e7498200910.1371/journal.pone.000749819834602
|
|
57.
|
DI TaiSL TsaiYM ChenActivation of nuclear
factor kappaB in hepatitis C virus infection: implications for
pathogenesis and
hepatocarcinogenesisHepatology31656664200010.1002/hep.51031031610706556
|
|
58.
|
JK OemC Jackel-CramYP LiHepatitis C virus
non-structural protein-2 activates CXCL-8 transcription through
NF-kappaBArch
Virol153293301200810.1007/s00705-007-1103-118074095
|
|
59.
|
W LinWL TsaiRX ShaoHepatitis C virus
regulates transforming growth factor beta1 production through the
generation of reactive oxygen species in a nuclear factor
kappaB-dependent
mannerGastroenterology138250925182518.e1201010.1053/j.gastro.2010.03.008
|
|
60.
|
RB RayR SteeleA BasuDistinct functional
role of hepatitis C virus core protein on NF-kappaB regulation is
linked to genomic variationVirus
Res872129200210.1016/S0168-1702(02)00046-112135786
|
|
61.
|
JC LeeWC ChenSF WuAnti-hepatitis C virus
activity of Acacia confusa extract via suppressing
cyclooxygenase-2Antiviral
Res893542201110.1016/j.antiviral.2010.11.00321075144
|
|
62.
|
JC LeeCK TsengSF WuFR ChangCC ChiuYC
WuSan-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus
replication and virus-induced cyclooxygenase-2 expressionJ Viral
Hepat18e315e324201110.1111/j.1365-2893.2010.01424.x21692943
|
